Compare Amylx Pharmaceuticals Inc (AMLX) vs Petróleo Brasileiro SA (PBR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Petróleo Brasileiro SA — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Petróleo Brasileiro SA trades at $17.95 (market cap $112.19B). The key difference: Petróleo Brasileiro SA is far larger — about 42.5× Amylx Pharmaceuticals Inc's market cap, and Petróleo Brasileiro SA pays a 9.42% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | PBR | |
|---|---|---|
Market Cap | $2.64B | $112.19B |
Sector | Health | Technology |
52-Week High | $24.19 | $22.03 |
52-Week Low | $7.82 | $11.54 |
Enterprise Value | $2.39B | $172.61B |
Dividend Yield | — | 9.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Petróleo Brasileiro SA
Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →
